Ratings 2CRSi

Equities

AL2SI

FR0013341781

Real-time Euronext Paris 07:57:09 2024-05-02 am EDT 5-day change 1st Jan Change
3.575 EUR -1.79% Intraday chart for 2CRSi -0.83% +138.33%

Strengths

  • Growth is a substantial asset for the company, as anticipated by dedicated analysts. Within the next three years, growth is estimated to reach 75% by 2026.
  • The earnings growth currently anticipated by analysts for the coming years is particularly strong.
  • The stock, which is currently worth 2024 to 0.64 times its sales, is clearly overvalued in comparison with peers.
  • Analysts covering this company mostly recommend stock overweighting or purchase.
  • The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
  • The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
  • The opinion of analysts covering the stock has improved over the past four months.
  • Consensus analysts have strongly revised their opinion of the company over the past 12 months.

Weaknesses

  • As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
  • With an expected P/E ratio at 60.67 and 11.74 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
  • The group usually releases earnings worse than estimated.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Computer Hardware

1st Jan change Capi. Investor Rating ESG Refinitiv
+138.33% 73.91M
C
+55.27% 84.78B
B-
-7.78% 27.15B
B-
-3.18% 21.37B
B
+0.52% 18.02B
C-
-16.76% 14.16B
B-
-7.67% 12.06B
A-
+7.01% 9.84B
C
+15.11% 10.01B
A-
-12.16% 9.81B
B-
Investor Rating
Trading Rating
-
ESG Refinitiv

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
-
Yield
-

Momentum

1 year Revenue revision
-
4 months Revenue revision
-
7 days Revenue revision
1 year EPS revision
-
4 months EPS revision
-

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality

Environment

Emissions
Innovation
Use of resources

Social

Social commitment
Human Rights
Product liability
Human Resources

Governance

CSR Strategy
Management
Shareholders

Controversy

Controversy

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes